Real-World Analysis May Clarify Role of Adjuvant Endocrine Therapy in Premenopausal HER2+ Breast Cancer
OncLive,
Jasmine Sukumar, MD The reduced likelihood of receiving adjuvant endocrine therapy and ovarian suppression in addition to…
Jasmine Sukumar, MD The reduced likelihood of receiving adjuvant endocrine therapy and ovarian suppression in addition to…
The use of a gonadotropin-releasing hormone (GnRH) agonist for ovarian suppression has become a more go-to treatment strategy…
In Partnership With: Treatment regimens that include ovarian suppression with a gonadotropin-releasing hormone agonist have…